How proteins affect heart cell communication and arrhythmias
Mechanisms by which phosphorylation and protein partners regulate Cx45
This study is looking at how a protein called Cx45 affects communication between heart cells and can lead to dangerous heart rhythms when it’s too high in failing hearts, helping us understand what causes these arrhythmias.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Nebraska Medical Center NIH-funded |
| Lab location | 1 site (Omaha, United States) |
| Project ID | NIH-10434133 on NIH RePORTER |
What this research studies
This research investigates the role of specific proteins, known as connexins, in heart cell communication and how their dysfunction can lead to dangerous heart rhythms, or arrhythmias. The focus is on understanding how the protein Cx45, which is usually present at low levels in healthy hearts, becomes overexpressed in failing hearts and contributes to arrhythmias. The study aims to explore the mechanisms by which the phosphorylation of Cx45 influences its interactions with other proteins, affecting the communication between heart cells. By conducting experiments both in laboratory settings and in living organisms, the research seeks to uncover the underlying causes of arrhythmias related to Cx45.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with heart diseases or arrhythmias, particularly those experiencing heart failure.
Not a fit: Patients with arrhythmias not related to connexin dysfunction or those without heart conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for patients with heart arrhythmias, improving their heart function and overall health.
How similar studies have performed: Other research has shown promising results in understanding the role of connexins in heart function, indicating that this approach has potential for significant findings.
Where this research is happening
Omaha, United States
- University of Nebraska Medical Center — Omaha, United States (Active)
Researchers
- Principal investigator: Sorgen, Paul L — University of Nebraska Medical Center
- Study coordinator: Sorgen, Paul L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.